Soteriou, Despina
Kubánková, Markéta
Schweitzer, Christine
López-Posadas, Rocío
Pradhan, Rashmita
Thoma, Oana-Maria
Györfi, Andrea-Hermina
Matei, Alexandru-Emil
Waldner, Maximilian
Distler, Jörg H. W.
Scheuermann, Stefan http://orcid.org/0000-0003-2449-1687
Langejürgen, Jens http://orcid.org/0000-0002-9694-3040
Eckstein, Markus
Schneider-Stock, Regine http://orcid.org/0000-0003-0482-531X
Atreya, Raja
Neurath, Markus F. http://orcid.org/0000-0003-4344-1474
Hartmann, Arndt
Guck, Jochen http://orcid.org/0000-0002-1453-6119
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB/TRR241 ‘IBDome’, SFB/TRR241 ‘IBDome’, SFB/TRR241 ‘IBDome’, DI 1537/22-1, SFB CRC1181, SFB TR221, SFB/TRR241 ‘IBDome’, SFB/TRR241 ‘IBDome’)
Interdisziplinäre Zentrum für Klinische Forschung (IZKF) Erlangen; Research Grant A79
Interdisziplinäre Zentrum für Klinische Forschung (IZKF) Erlangen; clinician scientist program step 2
Max-Planck-Gesellschaft
Article History
Received: 1 December 2021
Accepted: 22 February 2023
First Online: 6 April 2023
Competing interests
: S.S., J.L. and J.G. are co-founders of the company Fast Forward Discoveries GmbH, which commercializes the TG technology. D.S., M.K. and J.G. are named inventors on a patent application for the combination of TG and RT–DC for solid biopsy diagnosis. M.K. and J.G. are co-founders of the company Rivercyte GmbH, which commercializes diagnostic applications of deformability cytometry. The other authors declare no competing interests.